A total of 151 institutions have reported a stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 4,178,823 | 0 | 0.00% | $66,861,168.00 |
| FMR LLC | 31 Dec, 2025 | 3,702,718 | 3,615,405 | 4,140.74% | $59,243,480.00 |
| Alpha Wave Global, LP | 31 Dec, 2025 | 3,612,211 | 0 | 0.00% | $57,795,376.00 |
| Versant Venture Management, LLC | 31 Dec, 2025 | 2,656,888 | 0 | 0.00% | $42,510,208.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,692,006 | 218,902 | 14.86% | $27,072,096.00 |
| UBS Group AG | 31 Dec, 2025 | 1,571,738 | 370,122 | 30.80% | $25,147,808.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,321,202 | -9,084 | -0.68% | $21,139,232.00 |
| FRANKLIN RESOURCES INC | 31 Dec, 2025 | 1,096,334 | 509,250 | 86.74% | $17,541,344.00 |
| 72 Investment Holdings, LLC | 31 Dec, 2025 | 1,017,751 | 0 | 0.00% | $16,284,016.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 865,169 | -32,447 | -3.61% | $13,842,704.00 |
| Intrinsic Edge Capital Management LLC | 31 Dec, 2025 | 569,705 | 569,705 | 0.00% | $9,115,280.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 539,348 | 539,348 | 0.00% | $8,629,568.00 |
| STATE STREET CORP | 31 Dec, 2025 | 510,749 | 92,765 | 22.19% | $8,171,984.00 |
| C WorldWide Group Holding A/S | 31 Dec, 2025 | 500,000 | 500,000 | 0.00% | $8,000.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 491,898 | 402,110 | 447.84% | $7,870,368.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 489,432 | 358,706 | 274.40% | $7,830,912.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 463,495 | 221,382 | 91.44% | $7,415,920.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 461,075 | 6,179 | 1.36% | $7,378,622.00 |
| Granahan Investment Management, LLC | 31 Dec, 2025 | 431,100 | 239,703 | 125.24% | $6,897,600.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Dec, 2025 | 398,566 | 398,566 | 0.00% | $6,377,000.00 |